Literature DB >> 11176761

Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease.

J Jeppesen1, H O Hein, P Suadicani, F Gyntelberg.   

Abstract

BACKGROUND: A high triglyceride (TG)--low high-density lipoprotein cholesterol (HDL-C) level (TG > or =1.60 mmol/L [> or =142 mg/dL] and HDL-C < or =1.18 mmol/L [< or =46 mg/dL]) is associated with a high risk of ischemic heart disease (IHD), whereas a low TG--high HDL-C level (TG < or =1.09 [< or =97 mg/dL] and HDL-C > or =1.48 mmol/L [> or =57 mg/dL]) is associated with a low risk. Conventional risk factors tend to coexist with high TG--low HDL-C levels. We tested the hypothesis that subjects with conventional risk factors would still have a low risk of IHD if they had low TG--high HDL-C levels.
METHODS: Observational cohort study of 2906 men aged 53 to 74 years free of IHD at baseline.
RESULTS: During 8 years, 229 subjects developed IHD. Stratified by conventional risk factors-low-density lipoprotein cholesterol level (< or =4.40 mmol/L or >4.40 mmol/L [< or =170 mg/dL or >170 mg/dL] [median value]), hypertensive status (blood pressure >150/100 mm Hg or taking medication), level of physical activity (>4 h/wk or < or =4 h/wk), and smoking status (nonsmokers vs smokers)-the incidence in men with high TG--low HDL-C levels was 9.8% to 12.2% in the low-risk and 12.2% to 16.4% in the high-risk strata; the corresponding values in men with low TG--high HDL-C concentrations were 4.0% to 5.1% and 3.7% to 5.3%, respectively. Based on an estimate of attributable risk, 35% of IHD might have been prevented if all subjects had had low TG--high HDL-C levels.
CONCLUSION: Men with conventional risk factors for IHD have a low risk of IHD if they have low TG--high HDL-C levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11176761     DOI: 10.1001/archinte.161.3.361

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  42 in total

Review 1.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients.

Authors:  Tae Ik Chang; Elani Streja; Melissa Soohoo; Tae Woo Kim; Connie M Rhee; Csaba P Kovesdy; Moti L Kashyap; Nosratola D Vaziri; Kamyar Kalantar-Zadeh; Hamid Moradi
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-13       Impact factor: 8.237

3.  Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification?

Authors:  M M Pinkston; W S C Poston; R S Reeves; C K Haddock; J E Taylor; J P Foreyt
Journal:  Eat Weight Disord       Date:  2006-03       Impact factor: 4.652

4.  Study of the Use of Lipid Panels as a Marker of Insulin Resistance to Determine Cardiovascular Risk.

Authors:  Ruth Ann Bertsch; Maqdooda A Merchant
Journal:  Perm J       Date:  2015

5.  Relationship among 25-hydroxyvitamin D concentrations, insulin action, and cardiovascular disease risk in patients with essential hypertension.

Authors:  Fahim Abbasi; David Feldman; Michael P Caulfield; Feras M Hantash; Gerald M Reaven
Journal:  Am J Hypertens       Date:  2014-08-19       Impact factor: 2.689

Review 6.  Do persons with diabetes benefit from combination statin and fibrate therapy?

Authors:  Paul D Rosenblit
Journal:  Curr Cardiol Rep       Date:  2012-02       Impact factor: 2.931

7.  Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.

Authors:  Yunosuke Matsuura; Jenny E Kanter; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

8.  The association between triglycerides and incident cardiovascular disease: What is "optimal"?

Authors:  Tsion Aberra; Eric D Peterson; Neha J Pagidipati; Hillary Mulder; Daniel M Wojdyla; Sephy Philip; Craig Granowitz; Ann Marie Navar
Journal:  J Clin Lipidol       Date:  2020-05-06       Impact factor: 4.766

9.  NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Authors:  K E Corey; R Vuppalanchi; L A Wilson; O W Cummings; N Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2014-11-28       Impact factor: 8.171

Review 10.  The metabolic syndrome in hypertension: diagnostic and therapeutic implications.

Authors:  Josep Redon; Renata Cífková
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.